Clinigen signs global access deal with Galen for chemotherapy drug DaunoXome
Clinigen Group has signed a supply agreement with pharmaceutical firm Galen for chemotherapy drug DaunoXome.
Under the deal, Clinigen's Idis Global Access (GA) division will make the drug available on request in 20 European countries as well as Australia, New Zealand and Hong Kong.
Galen will retain the rights to supply DaunoXome in the UK and selected countries outside Europe.
Click on this link for more information.
